← FDA Drug Approvals (Drugs@FDA)

NITROFURANTOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2025-01-14

Drug application

FDA Application #
ANDA208909
Application type
Abbreviated New Drug Application (Generic)
Brand name
NITROFURANTOIN
Generic name
NITROFURANTOIN
Active ingredients
NITROFURANTOIN
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Prescription
Sponsor
SOMERSET THERAPS LLC
Manufacturer
Somerset Therapeutics, LLC
First approval
2025-01-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown